The Impact of COVID19 on Treatment Practices for Patients With Early Breast Cancer: A Cross-Sectional Study From a Large Cancer Center In Italy.

Fabio GirardiSabrina MariniFrancesca PorraSonia CarpentieriAlberto MarchetTania SaibeneMarcello Lo MeleTommaso GiarratanoCarlo Alberto GiorgiEleonora MioranzaCristina FalciGiovanni FaggioniFrancesca CaumoGaia GriguoloMaria Vittoria DieciValentina Guarneri

Published in: The oncologist (2023)

There was no evidence for major changes in the management of patients with EBC during 2019-2021 and no treatment delays were observed. Our findings suggest that more women presented with palpable nodules at diagnosis, but the stage distribution did not change over time. Validation on a larger cohort of patients is warranted to robustly assess the impact of the COVID19 pandemic on treatment practices for patients with EBC.

Keyphrases

healthcare
primary care
coronavirus disease
sars cov
physical activity
newly diagnosed
early breast cancer
pregnant women
prognostic factors
risk factors
metabolic syndrome
young adults
adipose tissue
combination therapy
skeletal muscle
squamous cell
peritoneal dialysis
patient reported
lymph node metastasis